This has been observed in analyses of the silencing of various chromatin remodelling factors in tumour cell cultures.
(Representational image: Wikimedia Commons)
This has been observed in analyses of the silencing of various chromatin remodelling factors in tumour cell cultures. (Representational image: Wikimedia Commons) 
Medicine

Mutations in Tumor Cells Discovered to be Frequently Associated with DNA-RNA Hybrids

MBT Desk

The study shows that chromatin and the factors regulating it prevent the formation of DNA-RNA hybrids, a source of genomic instability associated with cancer. These hybrids block replication, resulting in increased chromosomal cleavages and collisions between transcription and replication.

The research has shown that chromatin is a first barrier to protect the integrity of the genome. This has been observed in analyses of the silencing of various chromatin remodelling factors in tumour cell cultures.

In a study comparing their data with genome databases of tumour cells, they found that genome sites enriched in DNA-RNA hybrids match the sites with the highest frequency of mutations found in tumour cells. (Representational image: Wikimedia Commons)

In a study comparing their data with genome databases of tumour cells, they found that genome sites enriched in DNA-RNA hybrids match the sites with the highest frequency of mutations found in tumour cells. The work thus reveals for the first time that there is a direct association between DNA-RNA hybrids and cancer-associated mutations, suggesting that they are a risk factor in the development of tumours.

Aguilera’s lab has pioneered studies of the role of DNA-RNA hybrids in the development of genetic instability, and this new paper not only offers a better understanding of cellular control of hybrids and their regulation by epigenetic factors, but also points to the possibility that levels of DNA-RNA hybrids in cells could be used as a potential indicator of carcinogenic risk.

The paper, published in the journal Nature Communications, was funded by the Spanish State Research Agency and the European Research Council, among others. (MV/Newswise)

Breaking Bad Blood: How Rogue Neutrophils Help Lung Cancer Spread

Oncologists Should Re-evaluate Cancer Treatments Near the 'End-of-Life'

RPGRIP1L Gene: Prognostic Marker and Therapeutic Target in Breast Cancer

Building a Better Sarcasm Detector

Combining Joyful Activities with ‘Savoring’ Therapy Shows Positive Mental Health Results